Ipca Laboratories Limited is a fully backward integrated, Indian pharmaceutical company with a strong thrust on exports. IPCA is the largest manufacturers of few APIs which we produce right from the basic stage. More than half of our formulations business is backed by our own APIs. APIs and Formulations are produced at world-class manufacturing facilities. These facilities have been approved by leading drug regulatory authorities – US FDA, MHRA UK, TGA Australia, MCC South Africa, WHO Geneva, HPFB Canada, PMDA Japan, WHO Geneva, KFDA Korea, EDQM and LAGeSO Berlin MOH. Today, they are therapy leaders in antimalarials and rheumatoid arthritis in the Indian market, with a fast expanding presence in international market as well. IPCA has brand leadership in 4-5 therapeutic areas, for both Formulations and APIs. Four of our major branded Formulations are ranked among top 300 brands of India and they have emerged as one among the top exporters of APIs in the world.